Hovione Overview
- Year Founded
-
1959
- Status
-
Private
- Employees
-
2,600
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
1
- Investments
-
5
Hovione General Information
Description
Operator of a contract drug substance manufacturing company intended for making disease treatment faster and more affordable. The company's services specialize in drug testing, drug molecule screening, and particle engineering, and seeks partners for completion of the clinical development, regulatory approval, and commercialization, enabling medical scientists to develop new drugs in the fields of dermatology, ophthalmology and respiratory and target new routes of administration, expansion of indications and improved delivery.
Contact Information
Website
www.hovione.comCorporate Office
- Lindenstrasse 14
- 6340 Baar
- Switzerland
Corporate Office
- Lindenstrasse 14
- 6340 Baar
- Switzerland
Hovione Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Hovione Comparisons
Industry
Financing
Details
Hovione Competitors (30)
One of Hovione’s 30 competitors is Kindeva Drug Delivery, a Private Equity-Backed company based in Woodbury, MN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kindeva Drug Delivery | Private Equity-Backed | Woodbury, MN | ||||
| Patheon | Formerly PE-Backed | Waltham, MA | ||||
| Bend Bioscience (Formerly CoreRx) | Private Equity-Backed | Clearwater, FL | ||||
| PCI Pharma Services | Private Equity-Backed | Philadelphia, PA | ||||
| Catalent | Private Equity-Backed | Tampa, FL |
Hovione Patents
Hovione Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026163139-A1 | Β-lactoglobulin for use as antiviral agent | Pending | 31-Jan-2025 | ||
| WO-2026159667-A1 | Synthetic sugars as enablers for viscosity reduction of highly concentrated biological molecules | Pending | 24-Jan-2025 | ||
| WO-2026082944-A1 | High-density composite active particles comprising beta-lactoglobulin and api, compositions comprising same, and methods for the manufacture thereof | Pending | 17-Oct-2024 | ||
| WO-2026013055-A1 | Methods and systems for preparing feed solutions for spray drying | Pending | 09-Jul-2024 | ||
| WO-2025253015-A1 | A pharmaceutical product collection device, method, and pharmaceutical manufacturing system | Pending | 07-Jun-2024 | B65B57/20 |
Hovione Signals
Hovione Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Hovione Investments & Acquisitions (5)
Hovione’s most recent deal was a Joint Venture with ViSync Technologies. The deal was made on 19-Sep-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ViSync Technologies | 19-Sep-2024 | Joint Venture | Drug Delivery | ||
| ExtremoChem | 16-Nov-2023 | Merger/Acquisition | Specialty Chemicals | ||
| Oxular | 19-Jul-2016 | Early Stage VC | Drug Discovery | ||
| Hovione (Formulation Plant) | 19-Oct-2015 | Corporate Asset Purchase | Buildings and Property | ||
| Pfizer (Loughbeg API Site) | 11-Dec-2008 | Corporate Asset Purchase | Buildings and Property |
Hovione Exits (1)
Hovione’s most recent exit was on 19-Jul-2016 from Oxular. The exit was categorized as with 6 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Oxular | 19-Jul-2016 | Completed |
|
Hovione FAQs
-
When was Hovione founded?
Hovione was founded in 1959.
-
Where is Hovione headquartered?
Hovione is headquartered in Baar, Switzerland.
-
What is the size of Hovione?
Hovione has 2,600 total employees.
-
What industry is Hovione in?
Hovione’s primary industry is BPO/Outsource Services.
-
Is Hovione a private or public company?
Hovione is a Private company.
-
What is Hovione’s current revenue?
The current revenue for Hovione is .
-
Who are Hovione’s investors?
Explorer Investments has invested in Hovione.
-
Who are Hovione’s competitors?
Kindeva Drug Delivery, Patheon, Bend Bioscience (Formerly CoreRx), PCI Pharma Services, and Catalent are some of the 30 competitors of Hovione.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process